These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16406421)

  • 1. CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women.
    Ribeiro FS; de Amorim LM; de Almeida Simão T; Mendonça GA; de Moura Gallo CV; Pinto LF
    Toxicol Lett; 2006 Jun; 164(1):90-5. PubMed ID: 16406421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
    Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS
    Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Yamanaka H
    Anticancer Res; 2003; 23(6D):4941-6. PubMed ID: 14981949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tetranucleotide repeat polymorphism in the CYP19 gene and breast cancer susceptibility in a Greek population exposed and not exposed to pesticides.
    Dialyna I; Tzanakakis G; Dolapsakis G; Tsatsakis A
    Toxicol Lett; 2004 Jun; 151(1):267-71. PubMed ID: 15177662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
    Huang CS; Kuo SH; Lien HC; Yang SY; You SL; Shen CY; Lin CH; Lu YS; Chang KJ
    Oncologist; 2008 Jul; 13(7):751-60. PubMed ID: 18614591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.
    Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ
    Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
    Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
    Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
    Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women.
    Dick IM; Devine A; Prince RL
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E989-95. PubMed ID: 15613678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women.
    Baghaei F; Rosmond R; Westberg L; Hellstrand M; Eriksson E; Holm G; Björntorp P
    Obes Res; 2003 Apr; 11(4):578-85. PubMed ID: 12690088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
    Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
    Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants of CYP19 (aromatase) and breast cancer risk.
    Kristensen VN; Harada N; Yoshimura N; Haraldsen E; Lonning PE; Erikstein B; Kåresen R; Kristensen T; Børresen-Dale AL
    Oncogene; 2000 Mar; 19(10):1329-33. PubMed ID: 10713674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk.
    Zheng W; Gao YT; Shu XO; Wen W; Cai Q; Dai Q; Smith JR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):709-14. PubMed ID: 15159300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.
    Xita N; Lazaros L; Georgiou I; Tsatsoulis A
    Fertil Steril; 2010 Jun; 94(1):250-4. PubMed ID: 19324338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
    Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The (TTTA)n polymorphism of aromatase (CYP19) gene is associated with age at menarche.
    Xita N; Chatzikyriakidou A; Stavrou I; Zois Ch; Georgiou I; Tsatsoulis A
    Hum Reprod; 2010 Dec; 25(12):3129-33. PubMed ID: 20937744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.
    Healey CS; Dunning AM; Durocher F; Teare D; Pharoah PD; Luben RN; Easton DF; Ponder BA
    Carcinogenesis; 2000 Feb; 21(2):189-93. PubMed ID: 10657957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic variation in CYP19 and the risk of breast cancer.
    Baxter SW; Choong DY; Eccles DM; Campbell IG
    Carcinogenesis; 2001 Feb; 22(2):347-9. PubMed ID: 11181459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.
    Zúbor P; Vojvodová A; Danko J; Kajo K; Szunyogh N; Lasabová Z; Biringer K; Visnovský J; Dókus K; Galajda P; Plank L
    Neoplasma; 2006; 53(1):49-55. PubMed ID: 16416013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.